Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1377

1.

Active and Passive Smoking, BRAFV600E Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study.

Kim KN, Hwang Y, Kim K, Lee KE, Park YJ, Choi JY, Park DJ, Cho B, Kang D, Park SK.

Cancer Res Treat. 2019 Feb 20. doi: 10.4143/crt.2018.612. [Epub ahead of print]

2.

Korean First Prospective Phase II Study, Feasibility of Prone Position in Postoperative Whole Breast Radiotherapy: A Dosimetric Comparison.

Chung Y, Yu JI, Park W, Choi DH.

Cancer Res Treat. 2019 Feb 18. doi: 10.4143/crt.2018.423. [Epub ahead of print]

3.

Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea.

Kim HS, Nam CM, Jang SY, Choi SK, Han M, Kim S, Moneta MV, Lee SY, Cho JM, Novick D, Rha SY.

Cancer Res Treat. 2019 Feb 18. doi: 10.4143/crt.2018.476. [Epub ahead of print]

4.

Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program.

Lee J, Lim J, Kim Y, Kim HY, Goo JM, Lee CT, Jang SH, Lee WC, Lee CW, An JY, Ko KD, Lee MK, Choi KS, Park B, Lee DH.

Cancer Res Treat. 2019 Feb 19. doi: 10.4143/crt.2018.464. [Epub ahead of print]

5.

Body Cavity-Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma.

Shin J, Ko YH, Oh SY, Yoon DH, Lee JO, Kim JS, Park Y, Shin HJ, Kim SJ, Won JH, Yoon SS, Kim WS, Koh Y; Consortium for Improving Survival of Lymphoma investigator.

Cancer Res Treat. 2019 Feb 14. doi: 10.4143/crt.2018.555. [Epub ahead of print]

6.

Changes of Tumor Infiltrating Lymphocytes after Core Needle Biopsy and the Prognostic Implications in Early Stage Breast Cancer: A Retrospective Study.

Huang J, Chen X, Fei X, Huang O, Wu J, Zhu L, He J, Chen W, Li Y, Shen K.

Cancer Res Treat. 2019 Feb 12. doi: 10.4143/crt.2018.504. [Epub ahead of print]

7.

Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database.

Lee JS, Cho IR, Lee HW, Jeon MY, Lim TS, Baatarkhuu O, Kim DY, Han KH, Park JY.

Cancer Res Treat. 2019 Feb 12. doi: 10.4143/crt.2018.477. [Epub ahead of print]

8.

Surveillance Rate and its Impact on Survival of Hepatocellular Carcinoma Patients in South Korea: A Cohort Study.

Im S, Jang ES, Lee JH, Lee CS, Kim BH, Chung JW, Kim JW, Jeong SH.

Cancer Res Treat. 2019 Feb 12. doi: 10.4143/crt.2018.430. [Epub ahead of print]

9.

Prevalence of Women with Dense Breasts in Korea: Results from a Nationwide Cross-sectional Study.

Jo HM, Lee EH, Ko K, Kang BJ, Cha JH, Yi A, Jung HK, Jun JK; Alliance for Breast Cancer Screening in Korea (ABCS-K).

Cancer Res Treat. 2019 Jan 29. doi: 10.4143/crt.2018.297. [Epub ahead of print]

10.

The Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio before Radical Radiotherapy in Patients with Non-metastatic Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis.

Kim JS, Keam B, Heo DS, Han DH, Rhee CS, Kim JH, Jung KC, Wu HG.

Cancer Res Treat. 2019 Jan 29. doi: 10.4143/crt.2018.503. [Epub ahead of print]

11.

The Feasibility of Spinal Stereotactic Radiosurgery for Spinal Metastasis with Epidural Cord Compression.

Kim YJ, Kim JH, Kim K, Kim HJ, Chie EK, Shin KH, Wu HG, Kim IH.

Cancer Res Treat. 2019 Jan 29. doi: 10.4143/crt.2018.653. [Epub ahead of print]

12.

Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer.

Kim SJ, Kim S, Kim DW, Kim M, Keam B, Kim TM, Lee Y, Koh J, Jeon YK, Heo DS.

Cancer Res Treat. 2018 Dec 31. doi: 10.4143/crt.2018.486. [Epub ahead of print]

13.

Higher Age Puts Lung-Cancer Patients at Risk for Not Receiving Anti-cancer Treatment.

Choi WI, Choi J, Kim MA, Lee G, Jeong J, Lee CW.

Cancer Res Treat. 2018 Dec 31. doi: 10.4143/crt.2018.513. [Epub ahead of print]

14.

Prospective Validation of The Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative Chemotherapy.

Kim JW, Kim SH, Lee YG, Hwang IG, Kim JY, Koh SJ, Ko YH, Shin SH, Woo IS, Hong S, Kim TY, Baek JY, Kim HJ, Kim HJ, Lee MA, Kwon JH, Hong YS, Ryoo HM, Lee KH, Kim JH.

Cancer Res Treat. 2019 Jan 2. doi: 10.4143/crt.2018.451. [Epub ahead of print]

15.

Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance.

Sun XS, Liang YJ, Liu SL, Chen QY, Guo SS, Wen YF, Liu LT, Xie HJ, Tang QN, Li XY, Yan JJ, Tang LQ, Mai HQ.

Cancer Res Treat. 2019 Jan 4. doi: 10.4143/crt.2018.652. [Epub ahead of print]

16.

Atezolizumab in Patients with Pretreated Urothelial Cancer: a Korean Single-Center, Retrospective Study.

Hur JY, Kim Y, Kwon GY, Kang M, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Lee SJ, Park SH.

Cancer Res Treat. 2019 Jan 9. doi: 10.4143/crt.2018.604. [Epub ahead of print]

17.

Nomogram Development and External Validation for Predicting the Risk of Lymph Node Metastasis in T1 Colorectal Cancer.

Oh JR, Park B, Lee S, Han KS, Youk EG, Lee DH, Kim DS, Lee DS, Hong CW, Kim BC, Kim B, Kim MJ, Park SC, Sohn DK, Chang HJ, Oh JH.

Cancer Res Treat. 2019 Jan 17. doi: 10.4143/crt.2018.569. [Epub ahead of print]

18.

Inherited NBN Mutations and Prostate Cancer Risk and Survival.

Rusak B, Kluźniak W, Wokołorczyk D, Stempa K, Kashyap A, Gronwald J, Huzarski T, Dębniak T, Jakubowska A, Masojć B, Akbari MR, Narod SA, Lubiński J, Cybulski C; Polish Hereditary Prostate Cancer Consortium.

Cancer Res Treat. 2018 Dec 13. doi: 10.4143/crt.2018.532. [Epub ahead of print]

19.

Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.

Kim E, Kim K, Kim SH, Han SW, Kim TY, Jung SY, Park KJ, Koh J, Kang GH, Chie EK.

Cancer Res Treat. 2018 Dec 20. doi: 10.4143/crt.2018.434. [Epub ahead of print]

20.

Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy.

Yang J, Huang Y, Feng Y, Li H, Feng T, Chen J, Yin L, Wang W, Wang S, Liu Y, Song Y, Li Y, Jin J, Tan W, Lin D.

Cancer Res Treat. 2018 Dec 26. doi: 10.4143/crt.2018.527. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center